Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
126.92
-1.60 (-1.24%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Illumina Revenue
In the year 2025, Illumina had annual revenue of $4.34B, down -0.66%. Illumina had revenue of $1.16B in the quarter ending December 28, 2025, with 4.98% growth.
Revenue (ttm)
$4.34B
Revenue Growth
-0.66%
P/S Ratio
4.44
Revenue / Employee
$430,853
Employees
10,080
Market Cap
19.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 4.34B | -29.00M | -0.66% |
| Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | Pro | Pro | Pro |
| Dec 29, 2019 | Pro | Pro | Pro |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.28B |
| Agilent Technologies | 7.07B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Waters | 3.17B |
| Revvity | 2.86B |
ILMN News
- 12 days ago - DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows - PRNewsWire
- 14 days ago - Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease - PRNewsWire
- 19 days ago - Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 - PRNewsWire
- 26 days ago - Illumina Announces Changes to Board of Directors - PRNewsWire
- 5 weeks ago - Illumina and Labcorp expand collaboration to broaden access to precision oncology testing - PRNewsWire
- 6 weeks ago - Illumina advances preventive genomics through strategic consortium with Veritas Genetics - PRNewsWire
- 7 weeks ago - Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering - PRNewsWire
- 2 months ago - Illumina Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts